Navigation Links


Lorus in Medical News

AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing Standards

... TORONTO, May 6 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus" or the "Company") (TSX:...y the end of the extension period. About Lorus lorus is a biopharmaceutical company focused on the rese...forts and an acquisition and in-licensing program, lorus is building a portfolio of promising anticancer dr...

Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference

...b cast- TORONTO, Nov. 6 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical c...ies for healthcare companies and investors. About lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics announces election of three new Directors and appoints a new Chairman

... TORONTO, Sept. 19 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR; AMEX: LRP), a biophar...lified individuals to our Board. They all bring to lorus an exceptional level of knowledge and experience i...g with them, to enhance shareholder value." About lorus ...
Lorus in Medical Technology

Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference

...e presented on April 17, 2007. In this research, lorus screened a series of siRNAs to select a lead drug ... development of siRNA-1284 as an anticancer agent. lorus is also pursuing other cancer targets with its siR...r drug discovery and medical therapeutics. About lorus ...
Lorus in Biological Technology

Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008

... TORONTO, July 21 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (Lorus), a biopharmaceutical com...Phase I clinical study in cancer indications. lorus intends to submit an IND for LOR-253 by the Q...srael. Under the terms of the licensing agreement, lorus is entitled to receive payments in excess of ...

Lorus Therapeutics Receives $600 Thousand From Escrow Account

... TORONTO, July 16 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a b...ce on forward-looking statements due to the inherent uncertainty therein. lorus Therapeutics Inc.'s recent press releases are available through the Company...

Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program

... TORONTO, July 9 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" o...tected in Mexico under an earlier patent issued to lorus in 2003. Virulizin(R) has demonstrated significa...locally advanced and metastatic pancreatic cancer. lorus has reported that the overall survival data in thi...

Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)

...ivity - TORONTO, July 2 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" o...te (NCI) Cancer Therapy Evaluation Program (CTEP). lorus is collaborating with the Division of Cancer Treat...r growth and metastatic potential. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions

... TORONTO, May 5 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...Lorus' senior management team. Dr. Babaei joined lorus in 2006, where he has held the progressive positio...-for-profit organizations. Dr. Lee has been with lorus for ten years, most recently serving as the Direct...

Lorus initiates development program exploring novel route of administration for LOR-2040

... TORONTO, April 22 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical c...se of LOR-2040 in the treatment of bladder cancer. lorus intends to submit the IND during Q3, 2008, followi...r growth and metastatic potential. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040

...CR) - TORONTO, April 16 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...esented on April 16, 2008. In this presentation, lorus provided data on the preclinical development of LO...nked to the development of cancer. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)

...ales - TORONTO, April 8 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...ated Asher Nathan, Managing Director of Zoticon. lorus invites analysts and media to participate in a con... Virulizin(R) is a registered trademark owned by lorus Therapeutics Inc. About...

Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer

... TORONTO, Jan. 22 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR; AMEX: LRP), a biophar...rofessional skills and integrity." About Lorus lorus is a biopharmaceutical company focused on the rese...forts and an acquisition and in-licensing program, lorus is building a portfolio of promising anticancer dr...

Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia

... TRIAL TORONTO, Aug. 29 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...fficacy evaluation in a larger patient population. lorus expects the clinical trial to be completed by the end of 2008. The decision by lorus to advance clinical development of GTI-2040 is bas...
Other TagsHyperHyperHyperHyperClothFlexWear
(Date:11/27/2009)... , , BEDFORD, Mass., Nov. 27 /PRNewswire...(the "Company"), a supplier of precision technolog...ced that an annual meeting of the Company,s shareh...10. The time and location of the meeting will be ... the Company received a requisition notice from St...
(Date:11/27/2009)... , , KELOWNA, BC, Nov. 27 /PRNewswire/ - U...lready seeing prime time in wellness. A combinatio...mated data upload are solving a long term concern ...possible to accurately gauge and reward improved p...h Technologies is one of the first wellness suppli...
(Date:11/27/2009)... , Biotech firm Replikins... of the H1N1 virus genomic data. It shows that th... of 3.7 (s.d. 4.5) during the virus,s current outb... levels this week of 2.0 (s.d. 0.1). The H1N1 infe... Boston (PRWEB) November 27, 20...
(Date:11/27/2009)... ,, DALLAS,Nov.27/PRNewswire-USNewswire/--Co...reonly25yearsago,solidorgantransplantationisnowali...rymenandwomenwhogatheredattheWinspearOperaHouseinD...saroundtheworldtocelebratethe25thanniversaryofBayl...rsofsolidorgantransplantintheUnitedStates. ,, I...
(Date:11/27/2009)... , , SAN FRANCISCO, Nov. 27 /PRNewswire-Fi...B ) announced that Blair Lambert, CFO/COO, will pr...ch will be held at the May Fair Hotel in London, E....m. GMT. ,, To listen to a live broadcast of Th...ernet, please log on to www.gymboree.com, click on...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3
(Date:11/26/2009)...e of the Ocean,s most distinctive residents. ,Ever...e head shape, says Michelle McComb from Florida A...rk,s vision. ,Perhaps their visual field has been ...giving the sharks excellent stereovision and depth...ere two schools of thought on this theory. In 1942...
(Date:11/26/2009)...ve antlers, red deer have been caught in the hunte...re much more than decorative. They are lethal weap...Currey, from The University of York, UK, has been ... over half a century and has become fascinated by ...-standing collaboration with Tomas Landete-Castill...
(Date:11/26/2009)...orked out a way of using recordings of birdsong to...This is the first time sound recordings from a mic...stimates of bird species, populations. Because the... Society,s Journal of Applied Ecology , will also...vance in our ability to monitor whale and dolphin ...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Tough yet stiff deer antler is materials scientist's dream 2Ecologists sound out new solution for monitoring cryptic species 2 2411 5 Million in New Support to the Greater Grady Campaign 50187 1 2411 5 Million in New Support to the Greater Grady Campaign 50187 2Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010 12805 1Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010 12805 2Groups to Congress 3A Dont Sacrifice Patient Safety to Lower Health Costs 50184 1Groups to Congress 3A Dont Sacrifice Patient Safety to Lower Health Costs 50184 2
Other Contentscastscastscastscastsincontinenceincontinenceincontinenceincontinencetracttracttracttracttracttracttracttracturinationurinationurinationchemistrychemistrychemistrychemistrychemistrychemistrychemistrychemistrychemistrychemistrycollectioncollectioncollectioncollectioncollectioncollectioncollectioncollectioncollectionoutputoutputoutputoutputoutputoutputoutputoutput